Congratulation to Dr. Saima Hilal (Joint Staff at NUS Pharmacology) on being selected as a recipient of the prestigious Singapore – New Zealand Joint Grant Call for Leveraging AI for Healthy Ageing. This international initiative, jointly launched by AI Singapore (AISG) and the New Zealand Ministry of Business, Innovation & Employment (MBIE) in December 2024, aims to spur scientific advancements and foster collaboration between Singaporean and New Zealand researchers in artificial intelligence (AI) and healthcare.
Dr. Hilal’s project, “An AI-Driven Risk Score for Dementia Ready for Clinical Use,” was selected after a competitive evaluation process involving research teams from both countries. She will lead the effort in partnership with Professor Lynette Tippett from the University of Auckland, combining expertise in neuroscience, AI, and clinical practice to develop an innovative tool that assesses dementia risk in older adults.
The grant will support the development and clinical validation of an AI-powered system capable of providing personalized dementia risk scores. Such a tool could revolutionize early detection and intervention strategies, improving quality of life for seniors and reducing healthcare burdens related to age-associated cognitive decline.
For more details: http://aisingapore.org/announcing-the-grant-awardees-of-the-singapore-new-zealand-joint-grant-call-for-leveraging-ai-for-healthy-ageing/
